Clinical Trials Logo

Migraine clinical trials

View clinical trials related to Migraine.

Filter by:

NCT ID: NCT05415020 Recruiting - Migraine Clinical Trials

Determining the Utility of a Behavioral Intervention in Chronic Migraine

RLB
Start date: June 29, 2022
Phase: N/A
Study type: Interventional

This proposal will involve a pilot study to evaluate the feasibility, acceptability, and outcomes of a lifestyle behavior protocol in managing chronic migraine. Additionally, the proposal will investigate biomolecules that are uniquely involved in chronic migraine patients who respond to the protocol. Successful completion of this proposal will inform the design of a future full-scale behavioral clinical trial to control chronic migraine.

NCT ID: NCT05411978 Recruiting - Migraine Clinical Trials

Safety and Efficacy of Oral Idebenone for Preventive Treatment of Migraine in Adult Migraine Patients

Start date: May 9, 2022
Phase: Phase 4
Study type: Interventional

This is a multi-center, prospective, double-blind randomized controlled trial on a sample of patients with migraine. Subjects will only be enrolled when a physician or research assistant who is familiar with the study protocol is available to enroll patients. Written, informed consent will be obtained from each patient. Consent will include a discussion of the risks and benefits.

NCT ID: NCT05399485 Active, not recruiting - Migraine Clinical Trials

Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only)

Start date: August 9, 2022
Phase: Phase 3
Study type: Interventional

This study is being conducted to evaluate the efficacy, safety, and tolerability of rimegepant in Japanese subjects for the prevention of migraine.

NCT ID: NCT05399459 Completed - Migraine Clinical Trials

Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only)

Start date: August 9, 2022
Phase: Phase 3
Study type: Interventional

This study is being conducted to determine the appropriate dose of rimegepant in Japanese subjects, as well as to evaluate the efficacy, safety, and tolerability of rimegepant in Japanese subjects for the acute treatment of migraine.

NCT ID: NCT05382832 Not yet recruiting - Migraine Clinical Trials

Botox Vs Spinal Cord Stimulation in the Treatment of Refractory Migraine Clinical Trial

BTX/SCS/TMig
Start date: August 1, 2022
Phase: N/A
Study type: Interventional

The clinical trial is focused on the treatment of selected patients with a migraine after implantation of spinal cord stimulator (SCS) based on previous neurological examination. Patients will be randomized and divided into two groups. According to randomization patients will receive saline or botox into the epidural space. The efficacy of treatment will be compared and estimated in both groups during different SCS settings. Data will be collected in pre-set time frames.

NCT ID: NCT05377437 Completed - Migraine Clinical Trials

Natural Language Processing for Headache Medicine

Start date: August 28, 2020
Phase: N/A
Study type: Interventional

Headache disorders are diagnosed by clinical history taking and applying the criteria provided within the International Classification of Headache Disorders Third Edition (ICHD-3). To help patients and physicians in making the correct diagnosis, digital technologies based on natural language processing (NLP) approaches may help to identify headache disorders within naturally patient-provided speech. The research aims to develop statistical models through machine-learning NLP applications for the accurate and precise classification of headache disorders with headache expert given ICHD-3 diagnosis as the gold standard. Furthermore, the research also aims to develop statistical models through machine-learning NLP applications for the estimation of impact scores derived from validated headache questionnaires by using texts as input. Patients from the tertiary headache clinic will be recruited to provide oral narrative textual descriptions of their headache attack characteristics and burden of disease related to their headache disorders. The goal of the research is to develop accessible, evidence-based digital medical tools as low-effort applications for the correct diagnosis of headache disorders and estimation of burden of disease due to headache disorders.

NCT ID: NCT05375097 Completed - Migraine Clinical Trials

Real-world Impact of Erenumab on Sick-leaves, Health Care Resource Use and Comorbidities.

Start date: July 3, 2020
Phase:
Study type: Observational

This was a retrospective registry-based study utilizing data collected in association with clinical care of patients. All data was stored in electronic health records at Terveystalo data base, and no patients were contacted for the study.

NCT ID: NCT05372796 Completed - Migraine Clinical Trials

The Effects of Transcutaneous Occipital Nerve Stimulation and Instrument-Assisted Soft Tissue Mobilization on Patients With Chronic Migraine

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

In this study, it was aimed to examine the effects of two different treatments applied to the neck region, which have been popular in recent years, on migraine.The study included 45 female patients aged 20-50 years with migraine complaints. The patients were divided into 3 randomized groups: control group (n=15), Instrument-Assisted Soft tissue Mobilization (EDYDM) group (n=15) and on Occipital nerve TENS (OTES) group(n=15).Each group was given home exercise to their treatment. Home exercises applied 1 time per day for 5 weeks. Each exercise in the exercise program was performed with 10 repetitions

NCT ID: NCT05351918 Completed - Migraine Clinical Trials

Comparison of Two Different Migraine Acupuncture Treatment

Start date: February 1, 2022
Phase:
Study type: Observational

Headache is one of the most common clinical problems. Conventional drug therapy is more successful when complementary and integrative medicine approaches are combined to conventional treatment, as traditional Chinese medicine (TKM). The success of acupuncture therapy depends on the selection of acupuncture points according to TKM pathological mechanisms. Correct selection of points are needed to treat migraine headaches.Acupuncture reduces the consumption of analgesics. In this prospective, randomised study we will compered two methods of acupuncture stimulation: in the control group, all patients will receive the same local points, commonly used to treat migraine in our department, in the study group, local points will be selected according to the site of the headache.

NCT ID: NCT05337254 Completed - Migraine Clinical Trials

A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects

Start date: March 5, 2021
Phase: Phase 1
Study type: Interventional

Single-center, single-dose, open-label, 5-period crossover (in each part), pharmacokinetic and safety study.